Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Mar;5(2):66-70.
doi: 10.1200/JOP.0922004.

Quality of life predicts progression-free survival in patients with metastatic renal cell carcinoma treated with sunitinib versus interferon alfa

David Cella  1 , Joseph C Cappelleri, Andrew Bushmakin, Claudie Charbonneau, Jim Z Li, Sindy T Kim, Isan Chen, M Dror Michaelson, Robert J Motzer
Affiliations

Quality of life predicts progression-free survival in patients with metastatic renal cell carcinoma treated with sunitinib versus interferon alfa

David Cella et al. J Oncol Pract. 2009 Mar.

Abstract

In a randomized phase III trial, sunitinib was associated with significantly superior progression-free survival when compared with interferon alfa as first-line therapy in patients with metastatic renal cell carcinoma. This article investigates whether baseline quality of life and demographic and clinical variables were predictive for progression-free survival.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Relationship between progression-free survival and baseline quality-of-life variables. EQ-VAS, EuroQol Group's visual analog scale; FKSI-DRS, Functional Assessment of Cancer Therapy–Kidney Symptom Index–Disease-Related Symptoms subscale; FACT-G, Functional Assessment of Cancer Therapy–General scale.
See this image and copyright information in PMC

References

    1. Motzer RJ, Bander NH, Nanus DM: Renal-cell carcinoma. N Engl J Med 335:865-875, 1996 - PubMed
    1. Dharma-Wardene M, Au HJ, Hanson J, et al: Baseline FACT-G score is a predictor of survival for advanced lung cancer. Qual Life Res 13:1209-1216, 2004 - PubMed
    1. Efficace F, Biganzoli L, Piccart M, et al: Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. Eur J Cancer 40:1021-1030, 2004 - PubMed
    1. Lis CG, Gupta D, Granick J, et al: Can patient satisfaction with quality of life predict survival in advanced colorectal cancer? Support Care Cancer 14:1104-1110, 2006 - PubMed
    1. Maisey NR, Norman A, Watson M, et al: Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer 38:1351-1357, 2002 - PubMed